Barron’s Medical Journal Recommends Antioxidants, Gotu kola, Fennel And Ginseng

Barron’s Medical Journal Reporting From Rice University Bio-Research Center Houston, Texass

---

Houston, Texas ( AP) Barron’s Medial Journal is finding in our travel around the country Women who say that they

are first degree relatives of women with breast cancer. Barron’s ask the women have they had a genomic test. The reason for this question is that if your are a first degree relatives of a breast cancer Patient a genomic test can provide you with so much information. For An example are your going to get breast cancer , if so several different treatment options. Also a genomics test is the test that Ms Angelina Jolie took to make here decision about how to treat her breast cancer. To our surprise 90% of the the Women ask said that they have never heard of a genomic test.

---

Barron’s Medical decided to also write this article to talk about some of the things a Women can do if she has breast

cancer in her family. Based on our Research we recommend that a first degree relatives include in their diets Antioxidants, Gotu kola, Fennel and Ginseng. Here is some background on the above Items.

---

Antioxidants are substances that inactivate free radicals, highly unstable molecules that can damage cell membranes and scramble the genetic information (DNA) in cells. Free radicals are produced in the body during normal cell metabolism,

and at a higher rate following tissue injury or exposure to tobacco smoke, sunlight, x-rays, and other environmental influences. To fight these dangerous chemicals, the body deploys a powerful antioxidant defense system, but it is hypothesized that in some cases the quantity of free radicals may overwhelm the body's natural defenses. This in turn could theoretically accelerate or cause various illnesses.

Antioxidants are substances that may protect cells from damage caused by the unstable molecules known as free radicals. Damaging free radicals can come from many sources: sunlight, carcinogens in cigarette smoke and charred meat, chemicals such as benzene, and the heme iron found in red meat. Free radical damage to cells may lead to DNA damage, which can contribute to cancer risk.

---

Brought To You By Luxe Mattress

Antioxidants interact with and stabilize free radicals, thereby preventing some of the damage free radicals might cause. Examples of antioxidants include beta-carotene, lycopene, resveratrol, quercetin, anthocyanidin, vitamins C and E, and many other substances.

Fruit and vegetables are especially rich in antioxidants. In a study of 1,551 women with a history of breast cancer,

those with the highest plasma levels of carotenoids—a marker of vegetable intake—in their bloodstreams had a 43 percent lower risk of having a new breast cancer than those with the lowest carotenoid levels. Many of the foods in the table above have been specifically associated with a diminished risk of breast cancer.

Gotu kola is a creeping plant native to subtropical and tropical climates. Gotu kola has a long history of use in Ayurvedic medicine (the traditional medicine of India) to promote wound healing and slow the progress of leprosy. It was also reputed to prolong life, increase energy, and enhance sexual potency. 1 Other uses of gotu kola included treating skin diseases, anxiety, diarrhea, menstrual disorders, vaginal discharge, and venereal disease. Based on these many traditional indications, gotu kola was accepted as a drug in France in the 1880s. British physicians in Africa used a special extract to treat leprosy.

Gotu kola has a reputation for improving memory, and the positive results from a study in rats performed in 1992 produced a temporary rush of public interest in gotu kola as a " brain booster

The herb fennel has a long history of use as both food and medicine. Traditionally, it is said to act as a carminative, a term that means that it helps the body expel gas. Other traditional uses include increasing breast milk production, easing childbirth, soothing cough, promoting menstrual flow, soothing indigestion, and enhancing libido. Fennel is also a common ingredient in “gripe water,” a traditional (and highly alcoholic) preparation used for treating –

Asian ginseng is a perennial herb with a taproot resembling the shape of the human body. It grows in northern China, Korea, and Russia; its close relative, Panax quinquefolius , is cultivated in the United States. Because ginseng must be grown for 5 years before it is harvested, it commands a high price, with top-quality roots easily selling for more than $10,000. Dried, unprocessed ginseng root is called white ginseng, and steamed, heat-dried root is red ginseng. Chinese herbalists believe that each form has its own particular benefits. Ginseng is widely regarded by the public as a stimulant. According to everyone who uses it seriously, though, that isn't the right description. In traditional Chinese herbology, Panax ginseng was used to strengthen the digestion and the lungs, calm the spirit, and increase overall energy. When the Russian scientist Israel I. Brekhman became interested in the herb prior to World War II, he came up with a new idea about ginseng: He decided that it was an adaptogen .

In our travel we also see a need to inform breast cancer patients about Triple-negative Breast Cancer. "[Triple-negative] tends to grow very differently than 'regular' breast cancer, and we don't have the same tools to treat it," says Dr. Vahdat, as quoted by Cleveland.com. "There are far fewer options, and there's no triple-negative directed therapy, so far," she adds.

But among those women with metastatic triple-negative breast cancer who took the TM treatment for the study, 81 percent were found to not relapse in the 10 months following treatment. According to Dr. Vahdat and others, such results are promising, as between 50 and 70 percent of Stage 3 breast cancer patients, whose cancers have already spread to their lymph nodes, end up relapsing within five years of undergoing conventional treatment triple-negative breast cancers responded to therapies while others didn't. "We have been lumping things together that shouldn't be lumped together

The new classifications - four types called HER2 "enriched," luminal A, luminal B and basal-like - categorize breast cancers by their genomic structure using a dizzying array of data points not previously available that have identified new pathways for the cancer to do its damage, making it possible for researchers to identify new places to target disease.

In what could be seen as the most promising development of this breast cancer study, researchers determined that some basal-like cancers had more in common with an aggressive form of ovarian cancer known as "serous" than with other types of breast cancer. Two other types of breast cancer, accounting for most cases of the disease, arise from the luminal cells that line milk ducts. These cancers have proteins on their surfaces that grab estrogen, fueling their growth. Just about everyone with estrogen-fueled cancer gets the same treatment. Some do well. Others do not. The genetic analysis divided luminal cancers into two distinct subtypes. The luminal

A subtype had good prognoses while luminal B did not, suggesting that perhaps patients with luminal A tumors might do well with just hormonal therapy to block estrogen from spurring their cancers while luminal B patients might do better

with chemotherapy in addition to hormonal therapy. In some cases, genetic aberrations were so strongly associated with one or the other luminal subtype that they appeared to be the actual cause of the cancer. The better News is that Genomics is on the Clock. Genomics provide a faster cheaper more effective way to detect the Her2 gene by using Semiconductor Sequencing. A example of this technique is Hybrid Pharma Gennxeix Semiconductor Sequencing. "Quantum Theory" In Action for Breast Cancer Patients. A polymerase is an enzyme whose central function is associated with polymers of nucleic acids such as RNA and DNA. The primary function of a polymerase is the polymerization of new DNA or RNA against an existing DNA or RNA template in the processes of replication and transcription. In association with a Hybrid Pharma Gennxeix also uses a Visualize Real-Time Breast Cancer Data using Signal Stochastic Resonance Units Neurons Detection and Analysis for Breast Cancer model after McCulloch-Pitts.

Hybrid Pharma computer-assisted diagnosing of breast cancer from mammograms. Hybrid Pharma works is a genetic network simulation trained with tumor incidence data from knockout experiments. Gennxeix Biotech uses Semiconductor Sequencing Chips that create a direct connection between Biochemical and digital information, bringing these two languages together. Hybrid's chips are designed like any other semiconductor chips. Pairing proprietary semiconductor technology with sequencing chemistry a nucleotide is incorporated into a strand of DNA by a polymerase, a hydrogen ion is released. Gennxeix Biotech used a high-density array of micro-machined wells for bioctechnology process in a massive way. Each well holds a different DNA template. Beneath the wells is an ion-sensitive layer and beneath that a proprietary Ion sensor. HER2 in many patients respond differently. Genomics can be the GPS to Extend life in Breast Cancer Patients. formalin fixed, paraffin embedded techniques and Her-2 Approximately Where do you really come from? And how can this information Solve Breast Cancer? Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene. HER-2 can be resistant to low-doses of anthracycline-based Hybrid Pharma have demonstrated that they can be used to map DNase (deoxyribonuclease) DNA origins of replication. Hybrid Pharma Recent progress in microarray technology has been related to the development of high resolution microarrays which can map genomic alterations and constitutional variants in DNA copy number at an extremely high resolution for Breast Cancer chemotherapy. formalin fixed, paraffin embedded techniques and Her-2The Good News is that science has advanced. Sections of microarray provide targets for parallel in situ detection of DNA, RNA and protein targets in each specimen on the array. The better News is that Genomics is on the Clock. Genomics provide a faster cheaper more effective way to detect the Her2 gene by using Semiconductor Sequencing. A example of this technique is Hybrid Pharma Semiconductor Sequencing. "Quantum Theory" In Action for Breast Cancer Patients. A polymerase is an enzyme whose central function is associated with polymers of nucleic acids such as RNA and DNA. The primary function of a polymerase is the polymerization of new DNA or RNA against an existing DNA RNA template in the processes of replication and transcription. In association with a

Hybrid Pharma also uses a Visualize Real-Time Breast Cancer Data using Signal Stochastic Resonance Units Neurons Detection and Analysis for Breast Cancer model after McCulloch-Pitts. Hybrid Pharma computer-assisted diagnosing of breast cancer from mammograms. Hybrid Pharma Gennxeix works is a genetic network simulation trained with tumor incidence data from knockout experiments. Gennxeix Biotech uses Semiconductor Sequencing Chips that create a direct connection between Biochemical and digital information, bringing these two languages together. Hybrid's chips are designed like any other semiconductor chips. Pairing proprietary semiconductor technology with sequencing chemistry a nucleotide is incorporated into a strand of DNA by a polymerase, a hydrogen ion is released. Gennxeix Biotech used a high-density array of micro-machined wells for bioctechnology process in a massive way. Each well holds a different DNA template. Beneath the wells is an ion-sensitive layer and beneath that a proprietary Ion sensor. HER2 in many patients response differently. Genomics is the GPS to Extend life in Breast Cancer Patients

Radiation For Breast Cancer And Genes In Common Show An Increase in Cardiovascular Disease

Radiation For Breast Cancer And Genes In Common Show An Increase in Cardiovascular Disease

Barron’s Medical Journal Reporting from The University of Texas Medical School Houston, Texas

---

Radiation For Breast Cancer And Genes In Common Show An Increase in Cardiovascular Disease

---

Houston Texas ( AP )Genetic and genomic testing information will allow early and more accurate prediction and diagnosis of disease and of disease progression. Medicine is now oriented towards disease prevention rather than efforts to cure people at late stages of illness.Barrons Medical Journal ask CEO Rose Conrad of Sam Houston Biotech In Houston, Texas to discuss the correlation between breast cancer and heart disease.

Conrad was quick to point out that genomics will allows us all to live longer and her research indicated that people should know that genes “GEE and FBAT “ is common in Cardiovascular disease and Breast Cancer Patients .Cardiovascular disease (CVD) is a common cause of morbidity and mortality. While we understand many components of this risk, the ability to provide individualized treatment that maximizes efficacy and minimizes side effects is an elusive goal. Because CVD has high heritability, genomic diagnostic approaches can provide the basis for this by dissecting out the genetically distinct components of this risk.

Breast cancer is the most common cancer in women -- more than a million cases are diagnosed each year worldwide. When it's confined to the breast, most women get surgery to remove the lump, followed by several weeks of radiation to kill any lingering cancer cells and sometimes hormone or chemotherapy.

Age-specific risk estimates are available to help counsel and design screening strategies for women with a family history of breast cancer. Of all women with breast cancer, 5% to 10% may have a germ-line mutation of the genes BRCA1 and BRCA2. Specific mutations of BRCA1 and BRCA2 are more common in women of Jewish ancestry The estimated lifetime risk of developing breast cancer for women with BRCA1 and BRCA2 mutations is 40% to 85%. Carriers with a history of breast cancer have an increased risk of contralateral disease that may be as great as 5% per year. Ma le carriers of BRCA2 mutations are also at increased risk for breast cancerConrad pointed out that researchers studied the medical records of 2168 women in Sweden and Denmark who had radiation for breast cancer between 1958 and 2001. They

estimated that the heart was exposed to, on average, a total of 4.9 units of radiation—called grays—during radiation of the breast. The rate of major heart events was found to increase slightly with each gray. Major heart events included heart attack, the need to unblock or replace blood vessels to the heart, or death from a reduced blood supply to the heart (ischemic heart disease). For women who already had risk factors for heart disease, the risk of a major heart event increased a little more. But overall the increased risk was still very small.For example, for a 50-year-old woman with no pre-existing heart risk factors, a 3-gray dose of radiation would increase her risk of having a major heart event before age 80 by 0.9% (from 4.5% to 5.4%). If she had one or more pre-existing heart risk factors, a 3-gray dose of radiation would increase her risk of having a major heart event before age 80 by 1.7%.Radiation Treatments: Women treated with radiation for breast cancer are more likely to develop heart problems later in life, even with the lower doses used today, a troubling new study suggests. The risk comes from any amount of radiation, starts five years after treatment and lasts for decades. Some chemotherapy drugs are known to harm the heart muscle, but the new study shows radiation can hurt arteries, making them prone to harden and clog and cause a heart attack. Women who receive both treatments have both types of risk.Fitness can help, studies found few prospective studies have evaluated breast cancer mortality in relation to cardiorespiratory fitness (CRF), an objective marker of physiologic response to physical activity habits. The association between CRF and risk of death from breast cancer in the Aerobics Center Longitudinal Study. Women (N = 14,811), aged 20 to 83 year with no prior breast cancer history. maximal treadmill exercise test duration and was categorized for analysis as low (lowest 20% of exercise duration), moderate (middle 40%), and high (upper 40%). At baseline, all participants were able to complete the exercise test to at least 85% of their age-predicted maximal heart rate. This is a indication that Fitness is important to breast cancer patients. Skin Care for women with breast cancer is a major concern for breast cancer patients and their loves ones. Women that have to under go chemotherapy and radiation therapy skin care have improved over the years. Genomic science allows Researcher and Physicians to look at each breast cancer patient and recommend a treatment strategy to maintain skin management. Lets discus the different types of breast cancer. Breast cancer is a disease that occurs when malignant (cancer) cells form in the tissues of the breast. There are three main types of invasive breast cancer (cancer that has spread beyond the layer of tissue in which it developed and is growing into surrounding, healthy tissues).Invasive ductal carcinoma: Begins in the ducts that carry breast milk and is the most common type of breast cancer (8 in 10 women with breast cancer have this type) Invasive lobular carcinoma: Begins in the glands that make breast milk and is less common than invasive ductal carcinoma (1 in 10 women with breast cancer have this type) Inflammatory breast cancer: Found in the lymphatic system of the skin of the breast and is an uncommon type of breast cancer (1 percent to 3 percent of all breast cancer diagnoses are inflammatory breast cancer)In advanced cases, breast cancer cells may spread (metastasize) to other parts of the body via the blood stream or lymph system.Scientist say breast cancer chemotherapy treatment can cause your skin, hair, and nails to become brittle, dry, and sensitive. Cell turnover is diminished or halted all together during chemo treatments, meaning that the current cells of your skin may not be getting renewed like normal. This means that you need to treat your skin with care. The vitality of your skin, hair, and nails is going through the same struggles as the rest of your body. 1. Moisturizing your skin immediately after washing and toweling dry.For your body, this means applying moisturizer after the bath or shower.For your face, this usually means applying moisturizer in the morning and at night.For your hands, this means moisturizing after washing many times during the day.For your lips, this means using a hydrating lip balm throughout the day. 2. Cleansing your skin with gentle cleansing products only. Apply them only where you need them and be sure to rinse them off thoroughly with warm water.For your body, this means you typically only need to soap up the parts of your skin that have the body odor glands (apocrine glands) including your armpits, groin, buttocks, and feet. If you still have oily skin when you are on chemo, you’ll also need to use cleanser on the oily areas of your back, neck, and chest too. For your face, this means using the mildest cleanser that gets off your makeup and products, but that isn’t so harsh as to dry out your skin. Don’t shoot for that tight “squeaky clean” feeling after washing because it means that you removed too much of your natural oils and actually irritated your skin.For your hands, this means using cleanser only on your palms most of the time. Skin on the back of your hand rarely gets into germs and grime, and it’s fragile and prone to dryness. Also, the space between your fingers and under your rings trap cleanser, so be careful to rinse all the cleanser off well; retained cleanser will irritate and “burn” your skin, worsening some of the hand-skin problems that occur during chemo.

The First Lady Of The United States Of America Has The key To Unlock A Breast Cancer Cure:

The First Lady Of The United States Of America Has The key To Unlock A Breast Cancer Cure:

---

Dallas, TX ( AP ) , May 29, 2013 (GLOBE NEWSWIRE) –---- The First Lady Of The United States Of America Michelle Obama Has The key To Unlock A Breast Cancer Cure. Barron’s Medical Journal Research indicates that a breast cancer cure would be a reality 71 percent faster, provided Michelle Obama would chair a committee to ask the question where we are on a cure for breast cancer. Barron’s Medical Journal research also found that one of the major stumbling blocks for a breast cancer cure is the lack of collaboration and communication between the United States Universities, Genomic Scientist and the Pharmaceutical industry. The next concern is genomics science researching cancer is too broad. Too many scientists are trying to find a cure for too many diseases. What if for the next eight months 70 percent of the Scientists that benefits from Federal National Institute of Health grants would focus one hundred percent of that time on a cure for a breast cancer cure. Angelina Jolie has drawn the attention of the American public with her announcement that she has had a procedure to stop breast cancer from happening to her and the Surpreme Court making a major decision on BRCA1 and BRCA2. (Hereditary Breast Ovarian Cancer Syndrome (BRCA1 / BRCA2) BRCA1 Mutation - Average 65 percent lifetime risk for breast cancer - 40 percent to 60 percent lifetime risk for second breast cancer (not reappearance of first tumor) - Average 39 percent lifetime risk for ovarian cancer -increased risk for other cancer types, such as prostate cancer BRCA2 Mutation - Average 45 percent lifetime risk for breast cancer (in females) - 6 percent lifetime risk for breast cancer (in males) - Average 11 percent lifetime risk for ovarian cancer - increased risk for other cancer types, such as pancreatic, prostate, laryngeal, stomach cancer, and melanoma It is going to take most of the scientist and Medical Communities to develop a cure. Having one company Myriad own the primary genes, BRCA1 and BRCA2 genes to accomplish a cure is like saying Ford is the only company that can make automobiles. Barron’s Medical Journal says that it is as simple as the law of supply and demand the more companies that can develop a cure with our Mothers, Sisters, and Daughters genes, the faster a complete cure will be developed. To help you understand the issues here is some background on the matter. Barron’s Medical Journal reports that the Surpreme Court remanded the case of The Association for Molecular Pathology, et al., v. Myriad Genetics, Inc., et al (Docket No. 11-725) to the Federal Circuit Court of Appeals. The question is should one company have all the rights to a gene that is the core of breast cancer ? Docket No. 11-725 is the Surpreme Court case that concerns the patents held on the BRCA1 and BRCA2 genes, which are both closely associated with the risk of developing breast and ovarian cancer. The genes were isolated by Myriad Genetics and the University of Utah, and Myriad manufactures the only test currently available to identify the two genes. In July 2011, the appellate court ruled 2-to-1 in favor of Myriad, stating that the genes could be patented because they did not occur in isolation in nature. This reversed a decision made by a US District Court in New York in March 2010 that stated that Myriad could not patent the genes. The Surpreme Court made a decision regarding patents on molecular testing that prompted the nation’s highest judicial authority to ask the appellate court to reconsider its previous decision with regard to Myriad: The case of Mayo Collaborative Services, Mayo Medical Laboratories, et al., v. Prometheus Laboratories, Inc. (Docket No. 10-1150) concerned a blood test used to identify thiopurine metabolites formed when the body breaks down thiopurine drugs taken by patients with gastrointestinal and nongastrointestinal autoimmune diseases to determine whether a prescribing physician should raise or lower the drug dosage. Breast Cancer Patients Can Now Benefit From Every Scientist In The World Working On A Cure Sam Houston Our Science NoteBook is BRCA1 BRCA2 Compliant Sam Houston is clear to sale it's Science NoteBook to Breast Cancer Doctors. The Surpreme Court has ruled on Myriad Genetics Inc. case. The patent protection, Patent protection is important for companies that are focusing on personalized medicine, including Sam Houston Biotech Myriad Genetics Inc. (MYGN) and Novartis AG. (NOVN) The field involves determining whether a patient is genetically susceptible to a particular disease or would be especially responsive to certain medicine. On 26 March, the US Surpreme Court handed down a short summary disposition as the latest installment in a long-running case that questions whether human genes can be patented. The Court simply vacated the 2011 decision by the Court of Appeals for the Federal Circuit (CAFC), which upheld Myriad Genetics Inc's (Myriad) patents relating to the BRCA genes, and sent the case back down to the CAFC for rehearing in light of a Surpreme Court case on patenting laws of nature, handed down just six days earlier (Mayo Collaborative Services v Prometheus Laboratories, 10-1150) (Mayo). The History of Case 10-1150 In 2009, the Association for Molecular Pathology together with many others filed suit against Myriad, the US Patent Office, and others, seeking to overturn 15 claims in seven of Myriad’s patents. The patents at issue relate to both process claims (method for detecting increased risk of breast cancer) and composition-of-matter claims (the BRCA1 and BRCA2 isolated genes). In 2010, Judge Sweet in the US District Court (SDNY) held that both the genes and methods were not patentable. In relation to the genes, they were not ‘markedly different’ to naturally occurring genes. Myriad’s argument that the technique of purifying the genes rendered the compounds patent-eligible was rejected. Judge Sweet noted the dual nature of genes as both compositions of matter and carriers of information. The fact that, even after the purification process, the information provided by the genes remained the same meant that they were patentable products of nature. As for the method claims, Judge Sweet relied on a ‘machine or transfer’ (MOT) test developed in an earlier CAFC decision (Bilski v Kappos) to conclude that the claims to the process of analysis or comparison in the technique were no more than ‘abstract mental processes’. However, the Surpreme Court later qualified the CAFC opinion, leaving this aspect of Judge Sweet’s opinion particularly vulnerable to appeal. Unsurprisingly Myriad appealed, and last year the CAFC overturned parts of the first instance decision, finding that because isolated DNA had been ‘cleaved’ (covalent bonds in its backbone chemically severed) it was rendered a different molecule, just a fraction of a native DNA molecule, and thus patentable. However, on the method claims the CAFC largely upheld the prior decision, invalidating all claims except one on the basis that they were merely abstract mental processes. The surviving method claim was directed to a method for screening potential cancer therapies. This claim included a transformative step, satisfying the MOT test. How much guidance the Mayo case can provide for the CAFC, given that it deals with process patenting, rather than compositions of matter. In Mayo, the Surpreme Court found that a process for determining dosages for a person with auto-immune disease was patentable. The relationship between certain concentrations of metabolites in a patient’s blood and the likelihood of under or over-dosing were merely laws of nature. Accordingly, the claimed processes were unpatentable unless they contained steps that genuinely applied the laws of nature, rather than merely constituting an attempt to monopolies the natural correlation itself. The additional steps in the claims did not transform an patentable law of nature into a patent-eligible application. Myriad will now have to wait for the CAFC to consider and apply the ramifications of Mayo, and decide on the composition of matter issue – probably late 2012 or 2013. For this reason, some analysis’s are predicting the CAFC may well uphold Myriad’s composition claims. In any event, Myriad has a suite of other patents protecting its BRAC Analysis technique, which would likely deter others from its use, at least in the short term. So Myriad remains bullish on the issue, stating that it will ‘vigorously Angelina Jolie procedure is not the only way to deal with breast cancer. Genomics and Gastric bypass surgery -- decreases the incidence of Breast Cancer by 80% Gastric bypass procedures (GBP) is operations that divides the stomach into a small upper pouch and a much larger lower "remnant" pouch and then re-arranges the small intestine to allow both pouches to stay connected to it. Surgeons have developed several different ways to reconnect the intestine, thus leading to several different GBP names. Any GBP leads to a marked reduction in the functional volume of the stomach, accompanied by an altered physiological and physical response to food. Hybrid GenConnect Inc estimated 908,000 people in the U.S. had gastric bypass, gastric banding , or some other form of bariatric. Candidates for bariatric surgery include those who are morbidly obese, which for most people means being 100 or more pounds overweight or having a body mass index (BMI) of 40 or more. A 5-foot, 8 -inch person who weighs 250 or more would be considered morbidly obese, as would someone who is 6 feet tall and weighs at least 295 pounds. Hybrid GenConnect Inc and others studied 900,000 adults followed for 16 years, Calle, et al, found the death rate from cancer was increased by 52 percent in men and 62 percent in women when the initial BMI was 40 or more. Cancers of the esophagus, colon and rectum, liver, gall bladder, pancreas, kidney, non-Hodgkins lymphoma and multiple myeloma were increased in both men and women. Stomach and prostate cancer was increased in men. Breast, uterus, cervix and ovary cancer were increased in women. They estimated, on the basis of this study, that overweight and obesity could account for 14 percent of all cancer deaths in the United States in men and 20 percent in women. The newly reported study included 1,035 morbidly obese patients who underwent bariatric surgery between 1986 and 2002 and 5,746 patients matched for age, gender, and duration of morbid obesity who did not have surgery. During five years of follow-up, 21 (2%) surgically treated patients were diagnosed with cancer, compared to 487 (8.5%) of nonsurgically treated patients. The bariatric surgery patients had an 85% lower incidence of breast cancer, a 70% lower incidence of colon and pancreatic cancer, a 50% lower incidence of non-Hodgkin's lymphoma, and a 60% lower incidence of skin cancer Adding years to your life after being Diagnosed with breast cancer is to take a breast cancer test using semiconductor sequencing to find P53,P63,BRCA1 and BRCA2 the major genes related to hereditary breast cancer. Women who have inherited certain mutations in these genes have a high risk of developing breast cancer, ovarian cancer, and several other types of cancer during their lifetime. Hybrid GenConnect breast cancer Assay is a unique diagnostic tests that can help patients and their doctors make informed, individualized treatment decisions. The American Society of Clinical Oncology® (ASCO®) and the National Comprehensive Cancer Network® (NCCN®) have included that genomics assay in their guidelines as an option to predict whether certain patients will benefit from different Therapies. defend’ its claims because of their ‘great importance to the medical, pharmaceutical, biotechnology and other commercial industries’. Life Science Companies are free to find A Cure for Breast Cancer using Genomics. April 15, 2013: The United States Surpreme Court ....... "Punted To The Summer " .... What Happen: Myriad Genetics lawyer Gregory A. Castanias argued that justices could think about their invention like a baseball bat. "A baseball bat doesn't exist until it's isolated from a tree. But that's still the product of human invention to decide where to begin the bat and where to end the bat," he said. Chief Justice Roberts did not accept that argument........ In Barron's Medical Journal Opinion .........Giving Myriad Genetics Time to accept that the fact That In the Metaphor ..." Is It Natural Or Organic " BRCA 1 & 2 are Natural And Can Not Be Patent ...... They will Phrase off a Piece of the process and make that portion Patentable. Michelle Obama and all of the S.T.E.M Majors together can come up with a cure before the end of President Obama second term.